Interse ENT报告Propel鼻窦植入物的真实证据研究的积极数据

08:02 AM EST, 01/25/2022 (MT Newswires) -- Intersect ENT (XENT) reported positive results Tuesday from a study of its Propel sinus implants using real-world evidence data from adult patients with chronic rhinosinusitis who underwent endoscopic sinus surgery.

The medical device company said the results show that patients receiving Propel sinus implants after sinus surgery had lower healthcare resource utilization over an 18-month postoperative period compared with patients who did not receive an implant.

"These results clearly demonstrate a positive impact of the Propel sinus implants," said President and Chief Executive Officer Thomas West.